Hostname: page-component-669899f699-7xsfk Total loading time: 0 Render date: 2025-04-25T03:35:56.077Z Has data issue: false hasContentIssue false
  • English
  • Français

Investigation of serum galanin, alarin, meteorin-like protein, and ischemia modified albumin levels in patients with schizophrenia

Published online by Cambridge University Press:  27 December 2024

Ozlem Gul Open the ORCID record for Ozlem Gul [Opens in a new window] ,
Huseyin Fatih Gul ,
Zozan Parsanoglu  and
Ozlem Devrim Balaban
Ozlem Gul*
Affiliation:
Department of Psychiatry, Istinye University, Istanbul, Turkey
Huseyin Fatih Gul
Affiliation:
Kars Kafkas University, Kars, Turkey
Zozan Parsanoglu
Affiliation:
Bakirköy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey
Ozlem Devrim Balaban
Affiliation:
Bakirköy Prof. Dr. Mazhar Osman Research and Training Hospital for Psychiatric and Neurological Diseases, Istanbul, Turkey
*
Corresponding author: Ozlem Gul; Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The objective of the current research is to study the serum levels of ischemia modified albumin (IMA), a new oxidative stress indicator, and various peptides (galanin, alarin, and meteorin-like protein) that may affect the pathophysiology of schizophrenia, determine their relationship with clinical features and each other, and compare them to those in healthy controls.

Materials and Methods:

This is a cross-sectional study consisting of 45 individuals with schizophrenia who are in remission and 45 healthy individuals. The differences and relationships between categorical variables and serum protein levels of the patient and control groups were statistically analysed. Receiver operating characteristics analysis was used for the diagnostic decision-making properties of serum protein levels to predict the presence of the disease.

Results:

In comparison with the control group, the median levels of serum proteins galanin and alarin were statistically lower in the patient group, whereas METRNL and IMA levels were higher. Considering the predictive values of serum proteins in the diagnosis of the disease, it was observed that serum galanin, alarin, and IMA levels had a sensitivity and specificity higher than 80%, followed by METRNL with 73.3% sensitivity and 66.7% specificity.

Conclusion:

Our findings reveal galanin, alarin, meteorin-like protein, and IMA are important molecules with high sensitivity and specificity in diagnosing schizophrenia. Furthermore, we think that further studies are needed to use them as reliable parameters in terms of clinical course, classification, and prognosis in explaining the etiopathogenesis of the disease.

Keywords

Schizophreniagalaninalarinmeteorin-like proteinischemia modified albumin
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 36 , Issue 6 , December 2024 , pp. 485 - 494
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Abebe, EC, Mengstie, MA, Seid, MA and Dejenie, TA (2022) Regulatory effects and potential therapeutic implications of alarin in depression, and arguments on its receptor. Frontiers in Psychiatry 13, 1051235. DOI: 10.3389/fpsyt.2022.1051235.CrossRefGoogle ScholarPubMed
Ayano, Getinet (2016) Schizophrenia: a concise overview of etiology, epidemiology diagnosis and management: review of literatures. Journal of Schizophrenia Research 3(2), 2–7.Google Scholar
Bar-Or, D, Curtis, G, Rao, N, Bampos, N and Lau, E (2001) Characterization of the Co 2+ and Ni 2+ binding amino-acid residues of the N-terminus of human albumin. European Journal of Biochemistry 268(1), 42–48. DOI: 10.1046/j.1432-1327.2001.01846.x.CrossRefGoogle ScholarPubMed
Can, M, Varlibas, F, Guven, B, Akhan, O and Yuksel, GA (2013) Ischemia modified albumin and plasma oxidative stress markers in Alzheimer’s disease. European Neurology 69(6), 377–380. DOI: 10.1159/000339006.CrossRefGoogle ScholarPubMed
Ceylan, MF, Tural Hesapcioglu, S, Yavas, CP, Senat, A and Erel, O (2020) Serum ischemia-modified albumin levels, myeloperoxidase activity and peripheral blood mononuclear cells in autism spectrum disorder (ASD). Journal of Autism and Developmental Disorders 51(7), 2511–2517. DOI: 10.1007/S10803-020-04740-9.CrossRefGoogle Scholar
Eberhard, N, Mayer, C, Wagner, A, Bauer, HC, Sperk, G, Boehm, U and Kofler, B (2010) Distribution of the neuropeptide alarin in murine brain. Regulatory Peptides 164(1), 35–36. DOI: 10.1016/j.regpep.2010.07.087.CrossRefGoogle Scholar
Elshony, HS, Okda, MA and El-Kabany, RA (2021) Ischemia-modified albumin and fibulin-5 as diagnostic and prognostic markers for acute cerebrovascular disease. Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57(1), 1–8. DOI: 10.1186/s41983-020-00264-2.CrossRefGoogle Scholar
Ericson, E and Ahlenius, S (1999) Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission. Brain Research 822(1-2), 200–209. DOI: 10.1016/S0006-8993(99)01144-0.CrossRefGoogle ScholarPubMed
Fang, X, Zhang, T, Yang, M, Li, L, Zhang, C, Hu, W, Fan, X, Liu, H, Zhu, Z, Liu, D, Zheng, H, Gu, HF, Liu, R and Yang, G (2018) High circulating alarin levels are associated with presence of metabolic syndrome. Cellular Physiology and Biochemistry 51(5), 2041–2051. DOI: 10.1159/000495823.CrossRefGoogle ScholarPubMed
Flores-Burgess, A, Millón, C, Gago, B, Garciá-Durán, L, Cantero-Garciá, N, Puigcerver, A, Narvaéz, JA, Fuxe, K, Santín, L and Diáz-Cabiale, Z (2022) Galanin (1-15) enhances the behavioral effects of fluoxetine in the olfactory bulbectomy rat, suggesting a new augmentation strategy in depression. International Journal of Neuropsychopharmacology 25(4), 307–318. DOI: 10.1093/IJNP/PYAB089.CrossRefGoogle ScholarPubMed
Frederiksen, SO, Ekman, R, Gottfries, C-G, Widerlöv, E and Jonsson, S (1991) Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatrica Scandinavica 83(4), 273–277. DOI: 10.1111/j.1600-0447.1991.tb05539.x.CrossRefGoogle Scholar
Freimann, K, Kurrikoff, K and Langel, Ü. (2015) Galanin receptors as a potential target for neurological disease. Expert Opinion on Therapeutic Targets 19(12), 1665–1676. DOI: 10.1517/14728222.2015.1072513.CrossRefGoogle ScholarPubMed
Gul, HF, Yildirim, C, Erdogan, CE, Gul, O and Koc, N (2021) The role of galanin, alarin, irisin, PGC1-A and BDNF in the pathophysiology of Alzheimer’s disease. International Journal of Medical Science and Clinical Invention 8(06), 5498–5507. DOI: 10.18535/ijmsci/v8i06.09 CrossRefGoogle Scholar
Gül, HF, Yıldırım, C, Erdoğan, C, Gül, Ö. and Arslantürk, İ. (2021) Investigation of plasma PGC1-α, irisin, BDNF, GAL, and GALP levels in Parkinson’s disease. Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 6(2), 145–161. DOI: 10.51754/cusbed.948015.CrossRefGoogle Scholar
Gurumurthy, P, Borra, SK, Yeruva, RKR, Victor, D, Babu, S and Cherian, KM (2014) Estimation of ischemia modified albumin (IMA) levels in patients with acute coronary syndrome. Indian Journal of Clinical Biochemistry 29(3), 367–371. DOI: 10.1007/s12291-013-0367-3.CrossRefGoogle ScholarPubMed
Hökfelt, T, Barde, S, Xu, ZQD, Kuteeva, E, Rüegg, J, le Maitre, E, Risling, M, Kehr, J, Ihnatko, R, Theodorsson, E, Palkovits, M, Deakin, W, Bagdy, G, Juhasz, G, Prud’homme, HJ, Mechawar, N, Diaz-Heijtz, R and Ögren, SO (2018) Neuropeptide and small transmitter coexistence: fundamental studies and relevance to mental illness. Frontiers in neural circuits 12, 106. DOI: 10.3389/fncir.2018.00106.Google Scholar
Hökfelt, T and Wiesenfeld-Hallin, Z (2024) The therapeutic potential of galanin in the management of pain – a review article. Danish Medical Journal 71(2), 1–11. DOI: 10.61409/A10230653.CrossRefGoogle ScholarPubMed
, Kalkan ÖF, , Öztürk H, Şahin Z, Başoğlu H, Aydin Abidin S and Abidin, I (2023) Alarin potentiates ongoing epileptiform activity in rat brain slices: an in vitro electrophysiological study. Acta Neurobiol Exp (Wars) 84(1), 35–42. DOI: 10.55782/ane-2024-2520.CrossRefGoogle Scholar
Khajebishak, Y, Faghfouri, AH, Soleimani, A, Madani, S and Payahoo, L (2022) Exploration of meteorin-like peptide (metrnl) predictors in type 2 diabetic patients: the potential role of irisin, and other biochemical parameters. Hormone Molecular Biology and Clinical Investigation 0(0), 127–135. DOI: 10.1515/HMBCI-2022-0037.Google Scholar
Kirkpatrick, B and Miller, BJ (2013) Inflammation and schizophrenia. Schizophrenia Bulletin. 39(6), 1174–1179. DOI: 10.1093/schbul/sbt141.CrossRefGoogle ScholarPubMed
Kofler, B, Brunner, S, Koller, A, Wiesmayr, S, Locker, F, Lang, R, Botz, B, Kemény, À and Helyes, Z (2015) Contribution of the galanin system to inflammation. SpringerPlus 4(1), 1–32. DOI: 10.1186/2193-1801-4-S1-L57/METRICS.CrossRefGoogle ScholarPubMed
Lang, R, Gundlach, AL and Kofler, B (2007) The galanin peptide family: Receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacology and Therapeutics. Pergamon 115(2), 177–207. DOI: 10.1016/j.pharmthera.2007.05.009.CrossRefGoogle ScholarPubMed
Mathé, AA (1999) Neuropeptides and electroconvulsive treatment. The Journal of ECT 15(1), 60–75. DOI: 10.1097/00124509-199903000-00006.Google ScholarPubMed
Miao, Z-W, Hu, W-J, Li, Z-Y and Miao, C-Y (2020) Involvement of the secreted protein Metrnl in human diseases. Acta Pharmacologica Sinica 41(12), 1525–1530. DOI: 10.1038/s41401-020-00529-9.CrossRefGoogle ScholarPubMed
Mills, EG, Izzi-Engbeaya, C, Abbara, A, Comninos, AN and Dhillo, WS (2020) Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour. Nature Reviews Endocrinology 17(2), 97–113. DOI: 10.1038/s41574-020-00438-1.CrossRefGoogle ScholarPubMed
Mohamed, OS, Darwish, MM, Mousa, MM, Abd Elaziz, AEH and Mohamed, AK (2023) Impact of mode of anesthesia on ischemia modified albumin, operative conditions, and outcome in emergency craniotomies. Egyptian Journal of Anaesthesia 39(1), 1–10. DOI: 10.1080/11101849.2022.2154011.CrossRefGoogle Scholar
Oliveira Volpe, CM, Vaz, T, Rocha-Silva, F, Villar-Delfino, PH and Nogueira-Machado, JA (2020) Is galanin a promising therapeutic resource for neural and nonneural diseases? Current Drug Targets 21(9), 922–929. DOI: 10.2174/1389450121666200225112055.CrossRefGoogle ScholarPubMed
Pavlovschi, E, Pantea, V, Borovic, D and Tagadiuc, O (2021) Study of ischemia modified albumin (IMA) as a biomarker in hypertensive retinopathy. Medicine and Pharmacy Reports 94(2), 185–190. DOI: 10.15386/MPR-1815.CrossRefGoogle ScholarPubMed
Roche, M, Rondeau, P, Singh, NR, Tarnus, E and Bourdon, E (2008) The antioxidant properties of serum albumin. FEBS Letters 582(13), 1783–1787. DOI: 10.1016/j.febslet.2008.04.057. No longer published by Elsevier.CrossRefGoogle ScholarPubMed
Rothermundt, M, Arolt, V and Bayer, TA (2001) Review of immunological and immunopathological findings in schizophrenia. Brain, Behavior, and Immunity 15(4), 319–339. DOI: 10.1006/brbi.2001.0648.CrossRefGoogle ScholarPubMed
SAY, B, Dindar Badem, N and Ergun, U (2020) Serum levels of ischemic modified albumin (IMA) and prolidase in migraine subjects. Journal of Health Sciences and Medicine 3(1). DOI: 10.32322/jhsm.638466.CrossRefGoogle Scholar
Schmid, A, Karrasch, T and Schäffler, A (2021) Meteorin-like protein (Metrnl) in obesity, during weight loss and in adipocyte differentiation. Journal of Clinical Medicine 10(19), 4338. DOI: 10.3390/JCM10194338.CrossRefGoogle ScholarPubMed
Soriani, M, Pietraforte, D and Minetti, M (1994) Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Archives of Biochemistry and Biophysics 312(1), 180–188. DOI: 10.1006/abbi.1994.1297.CrossRefGoogle ScholarPubMed
Stenfors, C, Theodorsson, E and Mathé, AA (1989) Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain. Journal of Neuroscience Research 24(3), 445–450. DOI: 10.1002/JNR.490240315.CrossRefGoogle ScholarPubMed
Tatemoto, K, Rökaeus, Å., Jörnvall, H, McDonald, TJ and Mutt, V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Letters 164(1), 124–128. DOI: 10.1016/0014-5793(83)80033-7.CrossRefGoogle ScholarPubMed
Teixeira Mendes, C, Forlenza, OV and Gattaz, WF (2001) Galanin and alzheimer’s disease. Revista de psiquiatria clinica. Sao Paulo: Univ Sao Paulo, pp. 248–252.Google Scholar
Tunç, S, Atagün, Mİ., Neşelioğlu, S, Bilgin, YY, Başbuğ, HS and Erel, Ö. (2018) Ischemia-modified albumin: a unique marker of global metabolic risk in schizophrenia and mood disorders. Psychiatry and Clinical Psychopharmacology, 29(2), 123–129. DOI: 10.1080/24750573.2018.1517466.CrossRefGoogle Scholar
Unal, K, Topcuoglu, C and Yirun, MC (2018) Serum ischemia modified albumin (IMA) levels of patients with bipolar disorder in remission and healthy controls. Biomedical Research 29(12), 2672–2675. DOI: 10.4066/biomedicalresearch.29-18-337.CrossRefGoogle Scholar
Ushach, I, Arrevillaga-Boni, G, Heller, GN, Pone, E, Hernandez-Ruiz, M, Catalan-Dibene, J, Hevezi, P and Zlotnik, A (2018) Meteorin-like/Meteorin-β is a novel immunoregulatory cytokine associated with inflammation. The Journal of Immunology 201(12), 3669–3676. DOI: 10.4049/jimmunol.1800435.CrossRefGoogle ScholarPubMed
Ushach, I, Burkhardt, AM, Martinez, C, Hevezi, PA, Gerber, PA, Buhren, BA, Schrumpf, H, Valle-Rios, R, Vazquez, MI, Homey, B and Zlotnik, A (2015a) METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clinical Immunology 156(2), 119–127. DOI: 10.1016/j.clim.2014.11.006.CrossRefGoogle ScholarPubMed
Wang, M, Chen, Q, Li, M, Zhou, W, Ma, T, Wang, Y and Gu, S (2014) Alarin-induced antidepressant-like effects and their relationship with hypothalamus-pituitary–adrenal axis activity and brain derived neurotrophic factor levels in mice. Peptides 56, 163–172. DOI: 10.1016/J.PEPTIDES.2014.04.009.CrossRefGoogle ScholarPubMed
Wang, M, Zhou, W, Zhou, X, Zhuang, F, Chen, Q, Li, M, Ma, T and Gu, S (2015) Antidepressant-like effects of alarin produced by activation of trkB receptor signaling pathways in chronic stress mice. Behavioural Brain Research 280, 128–140. DOI: 10.1016/J.BBR.2014.11.039.CrossRefGoogle ScholarPubMed
Wang, S, Hwa, J and Varty, G (2005) Galanin receptors and their therapeutic potential. 5(4), 415–440. DOI: 10.1517/14728214.5.4.415.Google Scholar
Yao, JK, Reddy, RD and van Kammen, DP (2012) Oxidative damage and schizophrenia. CNS Drugs 15(4), 287–310. DOI: 10.2165/00023210-200115040-00004.CrossRefGoogle Scholar
Yao, JK, Reddy, RD and van Kammen, DP(2001) Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs 15(4), 287–310. DOI: 10.2165/00023210-200115040-00004.CrossRefGoogle Scholar
Zamanpoor, M (2020) Schizophrenia in a genomic era: A review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights. Psychiatric Genetics. Lippincott Williams and Wilkins 30(1), 1–9. DOI: 10.1097/YPG.0000000000000245.CrossRefGoogle Scholar
Zhang, S, Lei, Y, Sun, T, Gao, Z, Li, Z and Shen, H (2022) Elevated levels of metrnl in rheumatoid arthritis: Association with disease activity. Cytokine 159, 156026. DOI: 10.1016/J.CYTO.2022.156026.CrossRefGoogle ScholarPubMed
Supplementary material: File

Gul et al. supplementary material

Gul et al. supplementary material
Download Gul et al. supplementary material(File)
File 110.3 KB